EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase II)Multizentrische StudieOpen Access · CC BY-NC 4.0

PDE10A Inhibition in Schizophrenia: A Randomised, Placebo-Controlled Phase 2 Study of Alofropodect (CPL’36) in Patients Experiencing Acute Schizophrenia

Maciej Wieczorek iD, Napoleon Waszkiewicz iD, Ewa Gromniak-Haniecka, János M Réthelyi iD, Mykhaylo Pustovoyt iD, Yuriy Filts iD, Yuliya Blazhevych iD, Mikołaj Matłoka iD, Sylwia Janowska, Barbara Łapińska iD, Piotr J Rudzki iD, Radosław Jaźwiec iD und 1 weitere

CNS Drugs · 2026-09 · 40 (9) · 1295-1305

DOI: 10.1007/s40263-026-01317-5 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift CNS Drugs, online erschienen am 31.07.2026. Verfasst von Maciej Wieczorek und 12 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development Centre, Celon Pharma S.A., Kazuń Nowy, Poland. Hauptthemen laut MEDLINE: Schizophrenia, Antipsychotic Agents, Phosphoric Diester Hydrolases, Phosphodiesterase Inhibitors. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Narodowe Centrum Badań i Rozwoju.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaAntipsychotic AgentsPhosphoric Diester HydrolasesPhosphodiesterase InhibitorsHumansDouble-Blind MethodMaleAdultFemaleMiddle AgedTreatment OutcomeAcute DiseaseYoung AdultPsychiatric Status Rating ScalesAdolescent

Substanzen

Antipsychotic AgentsPhosphoric Diester HydrolasesPDE10A protein, humanPhosphodiesterase Inhibitors

Autor:innen und Institutionen

  • Research and Development Centre, Celon Pharma S.A., Kazuń Nowy, Poland.
  • Department of Psychiatry, Medical University of Białystok, Białystok, Poland.
  • Provincial Psychiatric Health Hospital named after Dr Józef Bednarz in Świecie, Świecie, Poland.
  • Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.
  • Department of Psychiatry, Narcology and Medical Psychology, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine.
  • Lviv Regional Clinical Psychiatric Hospital, Lviv, Ukraine.

ORCID-Profile: Maciej Wieczorek, Napoleon Waszkiewicz, János M Réthelyi, Mykhaylo Pustovoyt, Yuriy Filts, Yuliya Blazhevych, Mikołaj Matłoka, Barbara Łapińska, Piotr J Rudzki, Radosław Jaźwiec

Förderung

  • Narodowe Centrum Badań i Rozwoju

Zitieren

APA

Wieczorek, M., Waszkiewicz, N., Gromniak-Haniecka, E., Réthelyi, J. M., Pustovoyt, M., Filts, Y., Blazhevych, Y., Matłoka, M., Janowska, S., Łapińska, B., Rudzki, P. J., Jaźwiec, R., & Sierzputowska-Prarat, J. (2026). PDE10A Inhibition in Schizophrenia: A Randomised, Placebo-Controlled Phase 2 Study of Alofropodect (CPL’36) in Patients Experiencing Acute Schizophrenia. CNS Drugs, 40(9), 1295-1305. https://doi.org/10.1007/s40263-026-01317-5

Vancouver

Wieczorek M, Waszkiewicz N, Gromniak-Haniecka E, Réthelyi JM, Pustovoyt M, Filts Y, et al. PDE10A Inhibition in Schizophrenia: A Randomised, Placebo-Controlled Phase 2 Study of Alofropodect (CPL’36) in Patients Experiencing Acute Schizophrenia. CNS Drugs. 2026;40(9):1295-1305. doi:10.1007/s40263-026-01317-5

BibTeX
@article{Wieczorek2026,
  author = {Wieczorek, Maciej and Waszkiewicz, Napoleon and Gromniak-Haniecka, Ewa and Réthelyi, János M and Pustovoyt, Mykhaylo and Filts, Yuriy and Blazhevych, Yuliya and Matłoka, Mikołaj and Janowska, Sylwia and Łapińska, Barbara and Rudzki, Piotr J and Jaźwiec, Radosław and Sierzputowska-Prarat, Joanna},
  title = {PDE10A Inhibition in Schizophrenia: A Randomised, Placebo-Controlled Phase 2 Study of Alofropodect (CPL’36) in Patients Experiencing Acute Schizophrenia},
  journal = {CNS Drugs},
  year = {2026},
  volume = {40},
  number = {9},
  pages = {1295--1305},
  doi = {10.1007/s40263-026-01317-5}
}
Kostenlos starten →